Rho Kinase Inhibitors Prevent Endothelium-Dependent Contractions in the Rat Aorta
Authors:
- Judith C. MakJMJudith C. Mak
- Ricky Y. K. ManRMRicky Y. K. Man
- Paul M. VanhouttePVPaul M. Vanhoutte
- 1 May 2009
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 329 (2) , 820-826
Abstract
Rho kinase is involved in the pathogenesis of hypertension, which favors the occurrence of endothelium-dependent contractions. The present study was designed to determine the effects of two Rho kinase inhibitors, HA1077 [1-(5-isoquinolinesulfonyl)-homopiperazine (fasudil)] and Y27632 [(+)-(R)-trans-4-(1-aminoethyl)-N-(4-pyridyl) cyclohexane carboxamide dihydrochloride], on endothelium-dependent and -independent contractions. Isometric tension of 1-year-old spontaneously hypertensive rat and Wistar Kyoto aortae were measured. In the presence of Nω-nitro-l-arginine methyl ester, HA1077, and Y27632 reduced endothelium-dependent contractions caused by acetylcholine and the calcium ionophore 5-(methylamino)-2-[[2R,3R,6S,8S,9R,11R)-3,9,11-trimethyl-8-[(1S)-1-methyl-2-oxo-2-(1H-pyrrol-2-yl)-ethyl]-1,7-dioxaspiro[5.5]undec-2-yl]methyl]-4-benzoxazolecarboxylic acid (A23187). The Rho kinase inhibitors did not significantly affect prostacyclin production measured as 6-keto prostaglandin F1α. They nearly abolished endothelium-independent contractions to (5Z)-7-[(1R,4S,5S,6R)-6-[(1E,3S)-3-hydroxy-1-octenyl]-2-oxabicyclo-[2.2.1]hept-5-yl]-5-heptenoic acid (U46619), prostaglandin F2α, and phenylephrine. Western blotting revealed a comparable expression of Rho kinase in the aortae of the two strains. The reduction by Rho kinase inhibitors of endothelium-dependent contractions is mainly because of their direct effect on the vascular smooth muscle cells.Keywords
This publication has 34 references indexed in Scilit:
- Chronic intrauterine pulmonary hypertension increases endothelial cell Rho kinase activity and impairs angiogenesis in vitroAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxiaAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- In SHR aorta, calcium ionophore A-23187 releases prostacyclin and thromboxane A2 as endothelium-derived contracting factorsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Acetylcholine and sodium nitroprusside cause long-term inhibition of EDCF-mediated contractionsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Endothelium‐dependent contractions to acetylcholine, ATP and the calcium ionophore A 23187 in aortas from spontaneously hypertensive and normotensive ratsFundamental & Clinical Pharmacology, 2004
- Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertensionThe FASEB Journal, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Thromboxane A2 receptor antagonists inhibit endothelium-dependent contractions.Hypertension, 1990
- Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat.Hypertension, 1986
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980